Statisticians Role in the Pharmaceutical Industry - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Statisticians Role in the Pharmaceutical Industry

Description:

This presentation will probably involve audience discussion, which ... Neurosciences. Paxil. Wellbutrin SR. Imitrex ... Cardiovascular. Kredex/Coreg. Diabetes ... – PowerPoint PPT presentation

Number of Views:106
Avg rating:3.0/5.0
Slides: 27
Provided by: ruthcr
Category:

less

Transcript and Presenter's Notes

Title: Statisticians Role in the Pharmaceutical Industry


1
Statisticians Role in the Pharmaceutical Industry
  • This presentation will probably involve audience
    discussion, which will create action items. Use
    PowerPoint to keep track of these action items
    during your presentation
  • In Slide Show, click on the right mouse button
  • Select Meeting Minder
  • Select the Action Items tab
  • Type in action items as they come up
  • Click OK to dismiss this box
  • This will automatically create an Action Item
    slide at the end of your presentation with your
    points entered.
  • Nicole Blackman, PhD
  • Manager, Statistics
  • Oncology MDC Statistics and Programming
  • North Carolina State University
  • Department of Statistics
  • A Pipeline Issues Workshop - Sept 30, 2006

2
OUTLINE
  • Introduction
  • Drug Development Process
  • Statisticians Role
  • Statistical Considerations
  • Employment Considerations
  • QA

3
INTRODUCTION
4
What is statistics? A collection of techniques
for extracting information from data, and for
ensuring that the data collected contains the
desired information. What does statistics do for
us? Statistics provides an objective basis for
making decisions in the presence of uncertainty.
5
THE DRUG DEVELOPMENT PROCESS
  • Discovery to Marketing

6
Phases of Development
Phase IIIb/IV
Phase III
Phase II
Phase I
Pre-clinical
Research/Discovery
7
Phases (continued)
  • Discovery
  • Genomics
  • Combinatorial chemistry
  • High-throughput screening
  • Medicinal chemistry
  • Follow-up screening

Research/Discovery
8
Phases (continued)
  • Preclinical
  • Drug metabolism and pharmacokinetics
  • Animal toxicology safety assessment)
  • Chemical development
  • Analytical, Synthetic chemistry
  • Pharmaceutical development
  • Final drug formulation pills, liquid, aerosol,
    injectable

Pre-clinical
9
Phases (continued)
  • Phase I ( 6-12 months )
  • First time in humans
  • Healthy volunteers
  • Safety
  • Tolerability
  • Pharmacokinetics
  • Pharmacodynamics
  • Dose Response

Phase I
10
Phases (continued)
  • Phase II ( 24months)
  • Safety
  • Tolerability
  • Dose response for safety efficacy
  • Selection of dose for confirmatory clinical
    trials

Phase II
11
Phases (continued)
  • Phase III ( 24 - 36 months, or longer)
  • General patient population
  • Long-term, large studies
  • Confirm efficacy for regulatory registration
    (e.g. FDA)
  • RiskBenefit assessment
  • Product labeling

Phase III
12
Phases (continued)
  • Phase IIIb/IV
  • Post-approval market support
  • Publications
  • DTC ads
  • Detail aids
  • Post-approval requested studies
  • Regulatory requests
  • New indications
  • New formulations

Phase IIIb/IV
13
STATISTICIANS ROLE
14
Statisticians Role
  • In Research
  • Collaboration
  • Design clinical development program
  • Design and analyze clinical trials
  • Manage the report production process
  • Interpret results
  • Communicate results

15
Statisticians Role (continued)
  • In Development and Marketing
  • Develop final statistical statements on the
    efficacy and safety for marketing purposes
  • Develop publications, package inserts, etc.
  • New indications, line extensions, etc.

16
STATISTICAL CONSIDERATIONS
17
Common Statistical Issues
  • Specify the question and the hypothesis
  • Select the experimental unit
  • Choice of control or comparison group
  • Select the design
  • Ensure the sample size is sufficient
  • Neither too big nor too small

18
Common Statistical Issues (continued)
  • Randomly allocate experimental units to the
    treatment groups
  • Ensure groups are treated as exactly alike as
    possible
  • Blinding
  • Method of analysis
  • Control of false positive (Type I error)

19
EMPLOYMENT CONSIDERATIONS
20
The Job Search What a Company Looks For
  • Education
  • Communication skills
  • Initiative/Leadership skills
  • Team-working skills
  • Time/Project Management
  • Technical skills (e.g., programming and
    computing)

21
Roles by Degree
22
Employment Outlook
  • Job opportunities should remain favorable (2000 -
    2010, BLS)
  • Experienced statisticians very much in demand for
    the pharmaceutical / biotech industry
  • www.salary.com for latest on salary information
    and general job description

23
Other Research and Development ..
  • Anti-infectives
  • Augmentin SR
  • Zovirax
  • Trizivir ...
  • Neurosciences
  • Paxil
  • Wellbutrin SR
  • Imitrex ...
  • Diabetes
  • Avandia ...
  • Inflammation, Tissue Repair Oncology
  • Relafen/Relifex
  • Hycamtin
  • Zofran ...
  • Respiratory
  • Flovent
  • Advair ...
  • Vaccines
  • Havrix
  • Engerix-B
  • Infanrix
  • Twinrix
  • Cardiovascular
  • Kredex/Coreg
  • ...

24
www.gsk.comNicole.Blackman-1_at_gsk.com
GlaxoSmithKline Pharmaceuticals
Striving to make peoples lives healthier...
Preventing, diagnosing and curing disease
25
Back-up
26
Clinical Trial
  • A clinical trial is a prospective study comparing
    the effect and value of intervention(s) against a
    control in human subjects.
  • Prospective All subjects are followed forward,
    from a well-defined time point.
  • Intervention prophylactic, diagnostic or
    therapeutic (drug) agents, devices, regimes,
    procedures.
  • Control group Must be sufficiently similar to
    the intervention group at baseline in order that
    differences in outcome may be reasonably
    attributed to the action of the intervention.
Write a Comment
User Comments (0)
About PowerShow.com